Order Article Reprints

Vossen LM, Schurgers LJ, Van Varik BJ, Kietselaer BLJH, Vermeer C, Meeder JG, Rahel BM, Van Cauteren YJM, Hoffland GA, Rennenberg RJMW, et al. Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial). Nutrients. 2015; 7(11):8905-8915. https://doi.org/10.3390/nu7115443

Vossen, Liv M., Leon J. Schurgers, Bernard J. Van Varik, Bas L. J. H. Kietselaer, Cees Vermeer, Johannes G. Meeder, Braim M. Rahel, Yvonne J. M. Van Cauteren, Ge A. Hoffland, Roger J. M. W. Rennenberg, and et al. 2015. "Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial)" Nutrients 7, no. 11: 8905-8915. https://doi.org/10.3390/nu7115443

Vossen, L. M., Schurgers, L. J., Van Varik, B. J., Kietselaer, B. L. J. H., Vermeer, C., Meeder, J. G., Rahel, B. M., Van Cauteren, Y. J. M., Hoffland, G. A., Rennenberg, R. J. M. W., Reesink, K. D., De Leeuw, P. W., & Kroon, A. A. (2015). Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial). Nutrients, 7(11), 8905-8915. https://doi.org/10.3390/nu7115443